Michael Fossler

Vice President, Quantitative Clinical Pharmacology

Michael Fossler is Vice President, Quantitative Clinical Pharmacology at Cytel. From 1995 to 2000, Dr. Fossler was employed by the FDA as a clinical pharmacology reviewer in the Division of Metabolic and Endocrine Drug Products. In 1998, he was promoted to Senior Reviewer, and joined the Pharmacometrics group at FDA, where he was responsible for reviewing and performing population PK/PD analyses. He left the FDA in 2000 and joined the Clinical Pharmacokinetics Group at Dupont Pharmaceuticals, where he had major responsibility for PK/PD analyses in the cardiovascular and anti-inflammatory areas. Dr. Fossler has been with Cytel since 2022.